S-1/LV
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S-1/LV, covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer [Phase 2]